BioSpace News Archive

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
BridgeBio LLC

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.
Nitto BioPharma Inc.

Nitto BioPharma Inc. offers unique drug and nucleic acid (siRNA, miRNA, mRNA, etc) delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells.
RareCyte

RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy.
Lundbeck

Lundbeck is a biopharmaceutical company focused exclusively on neuroscience.
GenScript

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific.
Travere Therapeutics

Travere Therapeutics is determined to bring life-changing treatments, support, and hope to people with rare disease.
23andMe

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome.
Vaxcyte, Inc.

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
GRAIL, Inc.

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early.